ISRGIntuitive Surgical
$369.15+2.41%Real quote · delayedSurgical roboticsMedtech & life sciences · 10 peers →🏛️ Company factsSEC filings + FINRA official data
Annual revenue $10.1B · latest quarter up 18.5% YoY · profitable (FY net income $2.9B) · short activity above its recent average — bears adding.
FY revenue
$10.1B
2025-12
Latest Q YoY
+18.5%
Gross margin
66%
FY net income
$2.9B
Diluted EPS
$8
Short volume
64.8%
20d avg 54.1% · shorts building
🐋 5%+ ownership filings (last 180d)
The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.
- 2026-04-30passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
- 2026-03-27passive (13G)VANGUARD GROUP INC
🎯 Market expectations
Expectation reliability High · 76/100Nasdaq analyst consensus · the pre-news baseline
- Jun 2026$2.37 vs $2.02+17.33%
- Mar 2026$1.92 vs $1.63+17.79%
- Dec 2025$2.10 vs $1.83+14.75%
- Sep 2025$1.96 vs $1.58+24.05%
The takeaway
This company habitually beats by +18.5% — the next report has to clear that bar to count as good news.
Analyst estimates, not our forecast · not investment advice
What's moving this stock lately
1 direct · 0 2nd-order · 0 thematicRanked by impact strength · strength = estimated move × freshness decay (shorter-lived effects decay faster)
Cited as a true winner in AI-assisted surgical robotics that the ETF underweights, a pure sentiment effect
Also named: GOOGL · GOOG · BIDU · ABBNY · FANUY · KYCCF
🕰️ Price × news · engine report card
Drag to pan, scroll to zoom · real daily bars and volume
📜 Call history (newest first
6 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view
Sign up · free 7-day trial →Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.
Sign up · free 7-day trial →